Adverse Event Terminology

Working Group Chair(s)
Andrea Hanson
Health Products Regulatory Authority (HPRA), Ireland
European Union
Evan Jacobs
Food and Drug Administration (US FDA)
United States of America
Katie Burns (Maintenance Chair)
Therapeutic Goods Administration (TGA)
Australia
Membership
Regulators
Status
Current

The purpose of this working group is to:

  • establish IMDRF adverse event terminology including terms for medical device malfunction, evaluation result/conclusion, patient/user outcome, and part/component of a medical device
  • support the implementation and the use of the terminology through the provision of guidance documents and training materials
  • improve, harmonize and where necessary expand the terminology and systems being used to code information relating to medical device adverse events.

Do you want to find a code? Browse the terms now

Are you looking for guidance on adverse event terminology ? Browse here

Do you wish to submit a request to change the AET Terminology? See this page

Work Focus 2025
  • Finalisation of the Guidance Document on “Consideration for the selection of IMDRF Adverse Event Terminology (AET) codes and terms”
  • Development of training material to support the introduction of the Guidance Document on “Consideration for the selection of IMDRF Adverse Event Terminology codes and terms”
  • Finalisation of the updated Annual Maintenance Standard Operating Procedure (SOP)
  • Review of the N43 Terminologies for Categorized Adverse Event Reporting (AER): terms, terminology and codes and N44 Maintenance of IMDRF AE Terminologies
  • Review of the IMDRF AET working group website pages.

The latest guideline documents of Adverse Event Terminology and Coding are:

Technical/Informational document

Work items

IMDRF Adverse Event Terminology Maintenance

The maintenance of the final document will be managed via the dedicated 'Adverse Event Terminology Maintenance' web page.

IMDRF Adverse Event Terminology (Excel Format)

IMDRF AE terminology is provided in Excel format under IMDRF/AE WG/N43.

Since Edition 4 published on 20 April 2020, all annexes are provided in a new common format. The contents of each column are explained in a README file.

Trainings

Understanding Adverse Event Reporting is an essential part of ensuring that medical devices on the market are appropriately reported upon should post-market issues and incidents arise. This training may be considered of use to regulatory authorities, manufacturers as well as healthcare institutions.

Participants

Amanda Craig
Therapeutic Goods Administration (TGA)

Maria Gloria Vicente
Brazilian Health Regulatory Agency (ANVISA)
Stela Candioto Melchior
Brazilian Health Regulatory Agency (ANVISA)

Leanne Moore
Health Canada
Richard McAteer
Health Canada
Taran Nagra
Health Canada

Elke Troeltsch
Federal Institute for Drugs and Medical Devices (BfArM-Germany)
Jean-Francois Roche
European Commission
Kathrin Doerr
Federal Institute for Drugs and Medical Devices (BfArM-Germany)

Coco Nakamichi
Pharmaceuticals and Medical Devices Agency (PMDA)
Morikazu Seki
Pharmaceuticals and Medical Devices Agency (PMDA)

Lailing Liew
Health Sciences Authority (HSA)

Hye-Kyung Son
Ministry of Food and Drug Safety (MFDS)
Kook-Han Kim
Ministry of Food and Drug Safety (MFDS)

Cyrill Reber
Swissmedic
Eva Brombacher
Swissmedic
Sandra Tanner
Swissmedic

Graham Nash
Medicines and Healthcare products Regulatory Agency (MHRA)
Paras Shah
Medicines and Healthcare products Regulatory Agency (MHRA)

Evan Jacobs
Food and Drug Administration (US FDA)

Anita Sands
World Health Organization (WHO)
Leticia Josefina Megias Lastra
World Health Organization (WHO)